IC
CNTB

Ikarian Capital’s Connect Biopharma Holdings CNTB Stock Holding History

Ikarian Capital’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-144,600
Closed -$379K – 162
2026
Q1 		$379K Hold
144,600
– – 0.03% 131
2025
Q4 		$408K Buy
+144,600
New +$308K 0.03% 141

Other funds holding CNTB

6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Ikarian Capital's CNTB Position: Q2 2026 in Review

Ikarian Capital reduced its Connect Biopharma Holdings (CNTB) stake by 16% in Q2 2026, selling an estimated $2.06M and leaving 4,538,534 shares worth $10.8M. The position accounts for 1.16% of the portfolio, ranked #25.

Ikarian Capital first reported a position in CNTB in Q4 2021 and has held it in 10 quarters since. The position peaked at $13.5M in Q4 2025. 56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • Ikarian Capital held 4,538,534 shares of Connect Biopharma Holdings worth $10.8M as of Q2 2026.
  • Ikarian Capital sold 849,952 Connect Biopharma Holdings shares in Q2 2026, an estimated $2.06M.
  • Connect Biopharma Holdings made up 1.16% of Ikarian Capital's portfolio in Q2 2026, its #25 holding.
  • Ikarian Capital first reported a position in Connect Biopharma Holdings in Q4 2021 and has held it in 10 quarters since.
  • Ikarian Capital's Connect Biopharma Holdings position peaked at $13.5M in Q4 2025.
  • 56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.